Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 14

1.

Human biodistribution and dosimetry of ¹¹C-CUMI-101, an agonist radioligand for serotonin-1a receptors in brain.

Hines CS, Liow JS, Zanotti-Fregonara P, Hirvonen J, Morse C, Pike VW, Innis RB.

PLoS One. 2011;6(9):e25309. doi: 10.1371/journal.pone.0025309. Epub 2011 Sep 27.

2.

In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue.

Hendry N, Christie I, Rabiner EA, Laruelle M, Watson J.

Nucl Med Biol. 2011 Feb;38(2):273-7. doi: 10.1016/j.nucmedbio.2010.08.003. Epub 2010 Dec 28.

PMID:
21315283
3.

Ex vivo evaluation of the serotonin 1A receptor partial agonist [³H]CUMI-101 in awake rats.

Palner M, Underwood MD, Kumar DJ, Arango V, Knudsen GM, John Mann J, Parsey RV.

Synapse. 2011 Aug;65(8):715-23. doi: 10.1002/syn.20888. Epub 2011 Mar 21.

PMID:
21108237
4.

In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.

Milak MS, DeLorenzo C, Zanderigo F, Prabhakaran J, Kumar JS, Majo VJ, Mann JJ, Parsey RV.

J Nucl Med. 2010 Dec;51(12):1892-900. doi: 10.2967/jnumed.110.076257.

5.

In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer.

Milak MS, Severance AJ, Prabhakaran J, Kumar JS, Majo VJ, Ogden RT, Mann JJ, Parsey RV.

J Cereb Blood Flow Metab. 2011 Jan;31(1):243-9. doi: 10.1038/jcbfm.2010.83. Epub 2010 Jun 23.

6.

[18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.

Lemoine L, Verdurand M, Vacher B, Blanc E, Le Bars D, Newman-Tancredi A, Zimmer L.

Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):594-605. doi: 10.1007/s00259-009-1274-y. Epub 2009 Sep 30.

PMID:
19789870
7.

High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity.

Maurel JL, Autin JM, Funes P, Newman-Tancredi A, Colpaert F, Vacher B.

J Med Chem. 2007 Oct 4;50(20):5024-33. Epub 2007 Sep 6.

PMID:
17803293
8.

Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates.

Kumar JS, Prabhakaran J, Majo VJ, Milak MS, Hsiung SC, Tamir H, Simpson NR, Van Heertum RL, Mann JJ, Parsey RV.

Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1050-60. Epub 2007 Jan 13.

PMID:
17221184
9.

5-HT1 receptors.

Lanfumey L, Hamon M.

Curr Drug Targets CNS Neurol Disord. 2004 Feb;3(1):1-10. Review.

PMID:
14965240
10.

Psychopharmacology of 5-HT(1A) receptors.

Cowen PJ.

Nucl Med Biol. 2000 Jul;27(5):437-9. Review.

PMID:
10962247
11.

The spectrum of behaviors influenced by serotonin.

Lucki I.

Biol Psychiatry. 1998 Aug 1;44(3):151-62. Review.

PMID:
9693387
12.

Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.

Fletcher A, Cliffe IA, Dourish CT.

Trends Pharmacol Sci. 1993 Dec;14(12):41-8. Review.

PMID:
8122313
13.

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP.

Pharmacol Rev. 1994 Jun;46(2):157-203. Review.

PMID:
7938165
14.

Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors.

Pazos A, Probst A, Palacios JM.

Neuroscience. 1987 Apr;21(1):97-122.

PMID:
2955249

Supplemental Content

Support Center